Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
JPMorgan
MedTech
Renalytix aims for 2022 FDA clearance for kidney disease AI
After laying the groundwork for a broad launch of its KidneyIntelX AI, Renalytix is predicting that “2022 is going to be a heavy year of milestones."
Andrea Park
Jan 13, 2022 12:46pm
JPM22, Day 4: Gritstone wants new biomarker; Galapagos' rebound
Jan 13, 2022 8:40am
Roche taps Glytec app for its hospital bedside glucose monitor
Jan 12, 2022 9:05am
JPM22, Day 3: BeiGene promises 10 new molecules per year by 2024
Jan 12, 2022 8:16am
JPM22, Day 2: Freenome passes $1B in funds; Amgen taps Arrakis
Jan 11, 2022 9:10am
JPM22, Day 1: Bayer strikes a Mammoth deal and more
Jan 10, 2022 4:25am
